Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series.

Lael M Yonker,Zoe Swank,Tal Gilboa,Yasmeen Senussi,Victoria Kenyon, Lena Papadakis,Brittany P Boribong,Ryan W Carroll,David R Walt,Alessio Fasano

Critical care explorations（2022）

引用 16|浏览3

暂无评分

摘要

Larazotide appears safe and well-tolerated and may offer potential benefit as an adjuvant to immune-targeted therapies. Expansion of clinical trials is urgently needed to ascertain the clinical impact of larazotide on MIS-C.

查看译文

关键词

AT1001,larazotide,multisystem inflammatory syndrome in children,severe acute respiratory syndrome coronavirus 2 antigenemia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要